Chronic, dysregulated inflammation contributes to colitis-associated colorectal cancer (CRC), and the cGAS-STING pathway represents a central but therapeutically challenging node because both insufficient and excessive STING activity can be pathogenic. This evidence concerns the gene STING1 and colitis.